# Perfusion and Antihypertensive Therapy in Acute Ischemic Stroke

> **NCT02327793** · PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 65 (actual)

## Conditions studied

- Stroke, Acute

## Interventions

- **DRUG:** Nitroglycerin
- **DRUG:** Labetalol

## Key facts

- **NCT ID:** NCT02327793
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2015-07
- **Final completion:** 2015-08
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2017-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02327793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02327793, "Perfusion and Antihypertensive Therapy in Acute Ischemic Stroke". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02327793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*